Abstract: The SARS-CoV-2 virus pandemic had devastating effects on various aspects of life: clinical cases, ranging from mild to severe, can lead to lung failure and to death. Due to the high ...
Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results